Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02041533 |
|---|---|
| Brief Title: | An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) |
| First Submitted : | January 19, 2014 |
| First Submitted that Met QC Criteria : | January 19, 2014 |
| First Posted : | January 22, 2014 (Estimate) |
| Results First Submitted : | June 26, 2017 |
| Results First Submitted that Met QC Criteria : | June 26, 2017 |
| Results First Posted : | July 26, 2017 |
| Last Update Submitted that Met QC Criteria : | February 2, 2023 |
| Last Update Posted : | March 2, 2023 |